TORONTO, Aug. 04, 2021 (GLOBE NEWSWIRE) — Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2) and Fio Corporation (“Fio”) – together through their joint venture, Fionet Rapid Response Group (“FRR”) – is pleased to report on the previously announced sales agreement with the U.S. Government, through the U.S. Agency for International Development (“USAID”) 1, to deploy FRR’s Fionet Platform (“Fionet”) to fight a malaria pandemic in the Democratic Republic of the Congo (“DRC”). USAID and FRR have identified the first 144 remote community-based health sites to receive the medical platform which combines point-of-care, connected handheld devices, and AI-powered data software services.